1,721,010 research outputs found
sj-docx-1-tpp-10.1177_20451253231211574 – Supplemental material for Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area
No full textSupplemental material, sj-docx-1-tpp-10.1177_20451253231211574 for Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area by Grimur Høgnason Mohr, Carlo Alberto Barcella, Mia Klinten Grand, Margit Kriegbaum, Volkert Siersma, Margaret K. Hahn, Sri Mahavir Agarwal, Catrine Bakkedal, Lone Baandrup, Filip Krag Knop, Christen Lykkegaard Andersen and Bjørn Hylsebeck Ebdrup in Therapeutic Advances in Psychopharmacology</p
RIA glucagon in plasma and gut biopsies
No full textGastric and small intestinal mucosa biopsies were collected by upper enteroscopy and mixed meal tests (MMTs) were performed before and after Roux-en-Y gastric bypass (RYGB) surgery in eight morbidly obese individuals. The concentrations of glucagon were measured in plasma and gut mucosal biopsies using a radioimmunoassay (an in-house
RIA-based on a C-terminal-wrapping antibody (code 4305)). For further information, please see legends below the figures. </p
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes &ndash; a review
No full textIHS Negative control glucagon and GLP-1
No full textGastric and small intestinal mucosa biopsies were collected by upper enteroscopy and mixed meal tests (MMTs) were performed before and after Roux-en-Y gastric bypass (RYGB) surgery in eight morbidly obese individuals. Immunohistochemical staining of intestinal biopsy after RYGB. Control slide showing negative control for glucagon/glucagon-like peptide-1 (GLP-1
IHS gut biopsy - lack of co-localization of glucagon and PC2
No full textGastric and small intestinal mucosa biopsies were collected by upper enteroscopy and mixed meal tests (MMTs) were performed before and after Roux-en-Y gastric bypass (RYGB) surgery in eight morbidly obese individuals. Immunohistochemical staining of two
representative intestinal biopsies after RYGB showing glucagon (red) and the enzyme prohormone convertase 2 (PC2) (green) immunoreactive cells and lack of
co-localization (no yellow cells) (A, B).<br
IHS Negative control glucagon and PC2
No full textGastric and small intestinal mucosa biopsies were collected by upper enteroscopy and mixed meal tests (MMTs) were performed before and after Roux-en-Y gastric bypass (RYGB) surgery in eight morbidly obese individuals. Immunohistochemical staining of intestinal biopsy after RYGB. Control slide showing negative
control for glucagon/prohormone convertase 2 (PC2)</div
Table of clinical characteristics - RYGB
No full textClinical characteristics and metabolic profile of participants undergoing Roux-en-Y gastric bypass surgery. For more details, please see legend below the figure
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
